Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Prolidase could act as a diagnosis and treatment mediator in lung fibrosis.

Türkbeyler I, Demir T, Pehlivan Y, Kaplan DS, Ceribasi AO, Orkmez M, Aksoy N, Taysi S, Kisacik B, Onat AM.

Inflammation. 2012 Oct;35(5):1747-52. doi: 10.1007/s10753-012-9493-y.

PMID:
22717888
2.

The efficiency of a urotensin II antagonist in an experimental lung fibrosis model.

Onat AM, Turkbeyler IH, Pehlivan Y, Demir T, Kaplan DS, Taysi S, Ceribasi AO, Tutar E, Kisacik B.

Inflammation. 2012 Jun;35(3):1138-43. doi: 10.1007/s10753-011-9421-6.

PMID:
22205238
3.

Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.

Tzouvelekis A, Aidinis V, Harokopos V, Karameris A, Zacharis G, Mikroulis D, Konstantinou F, Steiropoulos P, Sotiriou I, Froudarakis M, Pneumatikos I, Tringidou R, Bouros D.

Respir Res. 2009 Feb 27;10:14. doi: 10.1186/1465-9921-10-14.

4.
5.

3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.

Gurrieri C, Piazza F, Gnoato M, Montini B, Biasutto L, Gattazzo C, Brunetta E, Cabrelle A, Cinetto F, Niero R, Facco M, Garbisa S, Calabrese F, Semenzato G, Agostini C.

J Pharmacol Exp Ther. 2010 Mar;332(3):785-94. doi: 10.1124/jpet.109.153049. Epub 2009 Dec 3.

6.

The ethical Kampo formulation Sho-seiryu-to (TJ-19) prevents bleomycin-induced pulmonary fibrosis in rats.

Yang CQ, Sun PY, Ding DZ, Moriuchi H, Ishitsuka Y, Irikura M, Irie T.

Biol Pharm Bull. 2010;33(8):1438-42.

7.

Effectiveness of palosuran in bleomycin-induced experimental scleroderma.

Demir T, Turkbeyler I, Kaplan DS, Pehlivan Y, Orkmez M, Tutar E, Taysi S, Kisacik B, Onat AM, Bagcı C.

Inflammation. 2013 Feb;36(1):75-9. doi: 10.1007/s10753-012-9521-y.

PMID:
22886350
8.

A novel segmental challenge model for bleomycin-induced pulmonary fibrosis in sheep.

Organ L, Bacci B, Koumoundouros E, Barcham G, Kimpton W, Nowell CJ, Samuel C, Snibson K.

Exp Lung Res. 2015 Apr;41(3):115-34. doi: 10.3109/01902148.2014.985806. Epub 2014 Dec 22.

PMID:
25531791
9.

[The comparative study of quartz dust and bleomycin-induced pulmonary fibrosis in rats].

Liu WW, Chen J, Liu YM, Li SM, Yu W, Chen JY, Zhang C, Tang LJ, Lin CL, Zhong XY.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2011 Jul;29(7):496-501. Chinese.

PMID:
22214153
10.

Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats.

Ozyurt H, Söğüt S, Yildirim Z, Kart L, Iraz M, Armutçu F, Temel I, Ozen S, Uzun A, Akyol O.

Clin Chim Acta. 2004 Jan;339(1-2):65-75.

PMID:
14687895
11.

Effects of erdosteine on bleomycin-induced lung fibrosis in rats.

Boyaci H, Maral H, Turan G, Başyiğit I, Dillioğlugil MO, Yildiz F, Tugay M, Pala A, Erçin C.

Mol Cell Biochem. 2006 Jan;281(1-2):129-37.

PMID:
16328965
12.

[The effect of erythromycin on NF-kappa B activation and cytokines mRNA expression in bleomycin-induced pulmonary fibrosis in rats].

Li Y, He B, Wang H.

Zhonghua Jie He He Hu Xi Za Zhi. 1999 Dec;22(12):725-7. Chinese.

PMID:
11776779
13.

Role of thioredoxin nitration in bleomycin-induced pulmonary fibrosis in rats.

Wang L, Song Y, Li X, Guo H, Zhang G.

Can J Physiol Pharmacol. 2016 Jan;94(1):59-64. doi: 10.1139/cjpp-2015-0121. Epub 2015 Jun 25.

PMID:
26372067
14.

Azithromycin reduces pulmonary fibrosis in a bleomycin mouse model.

Wuyts WA, Willems S, Vos R, Vanaudenaerde BM, De Vleeschauwer SI, Rinaldi M, Vanhooren HM, Geudens N, Verleden SE, Demedts MG, Thomeer M, Verbeken EK, Verleden GM.

Exp Lung Res. 2010 Dec;36(10):602-14. doi: 10.3109/01902148.2010.492895. Epub 2010 Sep 27.

PMID:
20874225
15.

[Effect of aerosolized STAT1 antisense oligonucleotides on the expressions of cytokines and collagens in lung tissue of pulmonary fibrosis rats induced by bleomycin].

Guo YN, Zhu C, Zeng M, Wang WJ, Li J, Fan XM.

Zhonghua Jie He He Hu Xi Za Zhi. 2009 Oct;32(10):752-6. Chinese.

PMID:
20079242
16.

Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.

Venkatesan N, Ouzzine M, Kolb M, Netter P, Ludwig MS.

Am J Physiol Lung Cell Mol Physiol. 2011 Feb;300(2):L191-203. doi: 10.1152/ajplung.00214.2010. Epub 2010 Nov 5.

17.

The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats.

Clozel M, Hess P, Qiu C, Ding SS, Rey M.

J Pharmacol Exp Ther. 2006 Mar;316(3):1115-21. Epub 2005 Nov 2.

18.

[A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation].

Zhang W, Lu XF, Zhang XM, Wu JJ, Jiang LD.

Zhong Xi Yi Jie He Xue Bao. 2008 Jan;6(1):60-7. Chinese.

19.

Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis.

Gao J, Huang Y, Li P, Xu D, Li J, Liu Y, Huang Z, Wu Q, Shao X.

J Ethnopharmacol. 2011 Jun 14;136(1):21-6. doi: 10.1016/j.jep.2011.03.013. Epub 2011 Mar 21.

PMID:
21421041
20.

Supplemental Content

Support Center